Get Premium to unlock powerful stock data

Asymmetry Capital Management, L.P. Buys Medtronic PLC, Sage Therapeutics Inc, DICE Therapeutics Inc, Sells Centene Corp, Sotera Health Co, Jazz Pharmaceuticals PLC

Author's Avatar
insider
Nov 04, 2021
Article's Main Image
Investment company Asymmetry Capital Management, L.P. (Current Portfolio) buys Medtronic PLC, Sage Therapeutics Inc, DICE Therapeutics Inc, Cytokinetics Inc, Quanterix Corp, sells Centene Corp, Sotera Health Co, Jazz Pharmaceuticals PLC, Adaptive Biotechnologies Corp, ESSA Pharma Inc during the 3-months ended 2021Q3, according to the most recent filings of the investment company, Asymmetry Capital Management, L.P.. As of 2021Q3, Asymmetry Capital Management, L.P. owns 29 stocks with a total value of $166 million. These are the details of the buys and sells.

For the details of Asymmetry Capital Management, L.P.'s stock buys and sells, go to https://www.gurufocus.com/guru/asymmetry+capital+management%2C+l.p./current-portfolio/portfolio

These are the top 5 holdings of Asymmetry Capital Management, L.P.
  1. Alkermes PLC (ALKS) - 373,382 shares, 6.92% of the total portfolio. Shares added by 22.32%
  2. Medtronic PLC (MDT) - 83,737 shares, 6.31% of the total portfolio. New Position
  3. Insulet Corp (PODD) - 36,732 shares, 6.28% of the total portfolio. Shares added by 26.91%
  4. Hologic Inc (HOLX) - 138,884 shares, 6.16% of the total portfolio. Shares added by 200.72%
  5. Sage Therapeutics Inc (SAGE) - 229,117 shares, 6.10% of the total portfolio. New Position
New Purchase: Medtronic PLC (MDT)

Asymmetry Capital Management, L.P. initiated holding in Medtronic PLC. The purchase prices were between $122.75 and $135.17, with an estimated average price of $129.47. The stock is now traded at around $120.173000. The impact to a portfolio due to this purchase was 6.31%. The holding were 83,737 shares as of 2021-09-30.

New Purchase: Sage Therapeutics Inc (SAGE)

Asymmetry Capital Management, L.P. initiated holding in Sage Therapeutics Inc. The purchase prices were between $40.26 and $57.37, with an estimated average price of $46.02. The stock is now traded at around $47.070000. The impact to a portfolio due to this purchase was 6.1%. The holding were 229,117 shares as of 2021-09-30.

New Purchase: DICE Therapeutics Inc (DICE)

Asymmetry Capital Management, L.P. initiated holding in DICE Therapeutics Inc. The purchase prices were between $31.92 and $37, with an estimated average price of $34.06. The stock is now traded at around $34.009800. The impact to a portfolio due to this purchase was 5.42%. The holding were 275,165 shares as of 2021-09-30.

New Purchase: Cytokinetics Inc (CYTK)

Asymmetry Capital Management, L.P. initiated holding in Cytokinetics Inc. The purchase prices were between $18.54 and $35.74, with an estimated average price of $29.35. The stock is now traded at around $38.470000. The impact to a portfolio due to this purchase was 5.29%. The holding were 246,336 shares as of 2021-09-30.

New Purchase: Quanterix Corp (QTRX)

Asymmetry Capital Management, L.P. initiated holding in Quanterix Corp. The purchase prices were between $45.91 and $59.67, with an estimated average price of $51.65. The stock is now traded at around $56.110000. The impact to a portfolio due to this purchase was 4.85%. The holding were 161,933 shares as of 2021-09-30.

New Purchase: PTC Therapeutics Inc (PTCT)

Asymmetry Capital Management, L.P. initiated holding in PTC Therapeutics Inc. The purchase prices were between $37.01 and $44.74, with an estimated average price of $41.15. The stock is now traded at around $41.710000. The impact to a portfolio due to this purchase was 4.83%. The holding were 215,985 shares as of 2021-09-30.

Added: Hologic Inc (HOLX)

Asymmetry Capital Management, L.P. added to a holding in Hologic Inc by 200.72%. The purchase prices were between $67.56 and $80.74, with an estimated average price of $74.96. The stock is now traded at around $71.610000. The impact to a portfolio due to this purchase was 4.11%. The holding were 138,884 shares as of 2021-09-30.

Added: Amicus Therapeutics Inc (FOLD)

Asymmetry Capital Management, L.P. added to a holding in Amicus Therapeutics Inc by 118.51%. The purchase prices were between $8.74 and $11.84, with an estimated average price of $10.24. The stock is now traded at around $12.410000. The impact to a portfolio due to this purchase was 2.03%. The holding were 653,976 shares as of 2021-09-30.

Added: Insulet Corp (PODD)

Asymmetry Capital Management, L.P. added to a holding in Insulet Corp by 26.91%. The purchase prices were between $260.36 and $307.27, with an estimated average price of $285.43. The stock is now traded at around $300.729300. The impact to a portfolio due to this purchase was 1.33%. The holding were 36,732 shares as of 2021-09-30.

Added: Alkermes PLC (ALKS)

Asymmetry Capital Management, L.P. added to a holding in Alkermes PLC by 22.32%. The purchase prices were between $23.37 and $32.13, with an estimated average price of $28.23. The stock is now traded at around $30.550000. The impact to a portfolio due to this purchase was 1.26%. The holding were 373,382 shares as of 2021-09-30.

Sold Out: Centene Corp (CNC)

Asymmetry Capital Management, L.P. sold out a holding in Centene Corp. The sale prices were between $59.73 and $74.7, with an estimated average price of $66.89.

Sold Out: Sotera Health Co (SHC)

Asymmetry Capital Management, L.P. sold out a holding in Sotera Health Co. The sale prices were between $22.25 and $26.52, with an estimated average price of $24.22.

Sold Out: Jazz Pharmaceuticals PLC (JAZZ)

Asymmetry Capital Management, L.P. sold out a holding in Jazz Pharmaceuticals PLC. The sale prices were between $128.64 and $184.79, with an estimated average price of $151.34.

Sold Out: Adaptive Biotechnologies Corp (ADPT)

Asymmetry Capital Management, L.P. sold out a holding in Adaptive Biotechnologies Corp. The sale prices were between $30.02 and $39.87, with an estimated average price of $36.27.

Sold Out: ESSA Pharma Inc (EPIX)

Asymmetry Capital Management, L.P. sold out a holding in ESSA Pharma Inc. The sale prices were between $7.76 and $29.37, with an estimated average price of $15.99.

Sold Out: Mereo BioPharma Group PLC (MREO)

Asymmetry Capital Management, L.P. sold out a holding in Mereo BioPharma Group PLC. The sale prices were between $2.2 and $3.17, with an estimated average price of $2.66.



Here is the complete portfolio of Asymmetry Capital Management, L.P.. Also check out:

1. Asymmetry Capital Management, L.P.'s Undervalued Stocks
2. Asymmetry Capital Management, L.P.'s Top Growth Companies, and
3. Asymmetry Capital Management, L.P.'s High Yield stocks
4. Stocks that Asymmetry Capital Management, L.P. keeps buying
Rating:
NaN / 5 ( votes)
Author's Avatar
WRITTEN BY

GuruFocus Screeners

Related Articles

Q&A with Gurus